Altarabsheh SE, Deo SV, Rababa’h A, Obeidat YM, Haddad O. Chronic ischemic mitral valve regurgitation and surgical perspectives. World J Cardiol 2018; 10(10): 141-144 [PMID: 30386491 DOI: 10.4330/wjc.v10.i10.141]
Corresponding Author of This Article
Salah Eldien Altarabsheh, MD, Consultant Cardiac Surgeon, Division of Cardiovascular Surgery, Queen Alia Heart Institute, Queen Rania St., Amman 11953, Jordan. salah936@yahoo.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Oct 26, 2018; 10(10): 141-144 Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.141
Chronic ischemic mitral valve regurgitation and surgical perspectives
Salah Eldien Altarabsheh, Salil V Deo, Abeer Rababa’h, Yagthan M Obeidat, Osama Haddad
Salah Eldien Altarabsheh, Division of Cardiovascular Surgery, Queen Alia Heart Institute, Amman 11953, Jordan
Salil V Deo, Division of Cardiovascular Surgery, Harrington Heart and Vascular Institute, Case Western Reserve University, Cleveland, OH 44106, United States
Abeer Rababa’h, Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan
Yagthan M Obeidat, Department of Cardiac Surgery, AlMana General Hospital, AL Khobar 31952, Saudi Arabia
Osama Haddad, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH 44195, United States
Author contributions: Altarabsheh SE and Deo SV had almost equal contributions in writing the manuscript; Obeidat YM and Haddad O had equal contribution in editing the manuscript; Rababa’h A reviewed the manuscript.
Conflict-of-interest statement: We do not have any relevant disclosure pertaining to this study.
Open-Access: This article is an open-access article, which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Salah Eldien Altarabsheh, MD, Consultant Cardiac Surgeon, Division of Cardiovascular Surgery, Queen Alia Heart Institute, Queen Rania St., Amman 11953, Jordan. salah936@yahoo.com
Telephone: +962-77-7181844 Fax: +962-2-7201075
Received: June 25, 2018 Peer-review started: June 26, 2018 First decision: July 9, 2018 Revised: August 4, 2018 Accepted: August 6, 2018 Article in press: August 7, 2018 Published online: October 26, 2018 Processing time: 123 Days and 7.1 Hours
Abstract
Chronic ischemic mitral valve regurgitation is a result of disturbed left ventricular geometry secondary to myocardial ischemia in the absence of intrinsic mitral valve pathology. It is a common complication after myocardial infarction, and patients who have ischemic mitral regurgitation (IMR) have a worse prognosis compared to patients who have ischemic heart disease alone, and this is directly related to the severity of IMR. Medical therapy has limited efficacy, and surgical options including various repair techniques and valve replacement had been tried with variable success. Still there is intense debate among surgeons whether to interfere with moderate degree IMR at the time of coronary artery revascularization.
Core tip: Chronic ischemic mitral valve regurgitation is a valvular dysfunction secondary to myocardial infarction. Debates among surgeons surround the decision to intervene and the type of intervention in moderate degree ischemic regurgitation. A comprehensive approach addressing the whole pathology of myocardial ischemia and ventricular dysfunction may be of value.
